Key result
In utero paroxetine exposure linked to neonatal withdrawal syndrome presenting with necrotizing enterocolitis.
Why the study?
What are the symptoms of neonatal paroxetine withdrawal syndrome following in utero exposure?
Population
Four term neonates exposed to paroxetine in utero
Design
Case_series
Authors
Loading...
Suggests need for neonatal monitoring after paroxetine exposure; hypothesis-generating and requires validation in larger cohorts.
Case Report (n=4)
What are the symptoms of neonatal paroxetine withdrawal syndrome following in utero exposure?
Neonates exposed to paroxetine in utero require close observation for withdrawal symptoms such as jitteriness and necrotising enterocolitis.
Joseph Stiskal (2001) conducted a case report in Neonatal paroxetine withdrawal syndrome (n=4). Paroxetine exposure in utero was evaluated on Symptoms of withdrawal syndrome (jitteriness, necrotising enterocolitis, vomiting, irritability, hypoglycaemia). In utero exposure to maternal paroxetine (20-120 mg/day) was associated with withdrawal syndrome in four term neonates, presenting with jitteriness, necrotising enterocolitis, and other symptoms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: